Nephros (NEPH) Net Shares Issued and Repurchased (2015 - 2026)
Nephros (NEPH) posted Net Shares Issued and Repurchased of $42500.0 for Q1 2026, down 80.8% on a QoQ basis from $221304.0 in Q4 2025, and down 79.23% year-over-year from $204575.0 in Q1 2025.
Powered by 
Analysis
Nephros (NEPH) Net Shares Issued and Repurchased (2015 - 2026) Analysis & Trends
Nephros has reported Net Shares Issued and Repurchased for 12 years, with the latest figure at $42500.0 in Q1 2026.
- On a quarterly basis, Net Shares Issued and Repurchased fell 79.23% year-over-year to $42500.0 in Q1 2026; TTM through Mar 2026 was $42500.0, a 79.23% decrease from a year earlier, with the FY2025 full-year figure at $221304.0, up 7.16% from the prior year.
- Net Shares Issued and Repurchased was $42500.0 for Q1 2026 at Nephros, down from $221304.0 in the prior quarter.
- The five-year high for Net Shares Issued and Repurchased was $583089.0 in Q4 2023, with the low at $500.0 in Q2 2025.
- Average Net Shares Issued and Repurchased over 5 years is $161723.0, with a median of $89900.0 recorded in 2023.
- The sharpest annual moves came in 2022 and 2025: Net Shares Issued and Repurchased jumped 1891.67% in 2022, then tumbled 99.41% in 2025.
- Over 5 years, Net Shares Issued and Repurchased stood at $340260.0 in 2022, then soared by 71.37% to $583089.0 in 2023, then sank by 64.58% to $206510.0 in 2024, then rose by 7.16% to $221304.0 in 2025, then plunged by 80.8% to $42500.0 in 2026.
- The last three Net Shares Issued and Repurchased figures came in at $42500.0 (Q1 2026), $221304.0 (Q4 2025), and $14729.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | - |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | - |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | - |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | - |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | - |
| 10 | Nephros | 48.31 Mn | 43.62 Mn | 4.03 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 42,500.00 |
| Dec 31, 2025 | 221,304.00 |
| Sep 30, 2025 | 14,729.00 |
| Jun 30, 2025 | 500.00 |
| Mar 31, 2025 | 204,575.00 |
| Dec 31, 2024 | 206,510.00 |
| Jun 30, 2024 | 85,198.00 |
| Dec 31, 2023 | 583,089.00 |
| Sep 30, 2023 | 6,000.00 |
| Jun 30, 2023 | 357,165.00 |
| Mar 31, 2023 | 89,900.00 |
| Dec 31, 2022 | 340,260.00 |
| Sep 30, 2022 | 19,615.00 |
| Jun 30, 2022 | 239,000.00 |
| Mar 31, 2022 | 15,500.00 |
| Dec 31, 2021 | 391,156.00 |
| Sep 30, 2021 | 59,868.00 |
| Jun 30, 2021 | 12,000.00 |
| Mar 31, 2021 | 160,428.00 |
| Dec 31, 2020 | 291,648.00 |